Infection Risk in Patients with Complement-Mediated Neurological Disorders Receiving Eculizumab: Findings from Two Phase 3 Studies and Their Extensions in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+NMOSD) and Acetylcholine-Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis (AChR plus gMG)

被引：1

作者：

Levine, Todd ^{[1
]}

Mantegazza, Renato ^{[2
]}

Oreja-Guevara, Celia ^{[3
]}

Carrillo-Infante, Cynthia ^{[4
]}

Kaprielian, Roger ^{[5
]}

Shang, Shulian ^{[4
]}

Yountz, Marcus ^{[4
]}

Howard, James ^{[6
]}

机构：

[1] Phoenix Neurol Associates, Phoenix, AZ USA

[2] Fdn IRCCS Ist Neurol Carlo Besta, Via Celoria 11, I-20133 Milan, Italy

[3] Hosp Univ Clin San Carlos, Madrid, Spain

[4] Alex Pharmaceut, Boston, MA USA

[5] Alex Pharmaceut, Vaughan, ON, Canada

[6] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1829

引用

页数：4